These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3274050)

  • 21. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.
    Brodsky FM; Parham P
    J Immunol; 1982 Jan; 128(1):129-35. PubMed ID: 6172474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and characterization of a human monoclonal IgG antibody specific for HLA-B12.
    Siemoneit K; Wölpl A; Wegener S; Ernst M; Sonneborn HH; Goldmann SF
    Tissue Antigens; 1994 Jul; 44(1):25-33. PubMed ID: 7526486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A murine monoclonal antibody specific for a novel broad antigen associated with HLA-Bw4.
    Wong DM; Mittal KK
    Tissue Antigens; 1986 Jan; 27(1):10-4. PubMed ID: 2420023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid and efficient strategy to generate allele-specific anti-HLA monoclonal antibodies.
    Yamazaki S; Suzuki N; Saito T; Ishii Y; Takiguchi M; Nakauchi H; Watanabe N
    J Immunol Methods; 2009 Mar; 343(1):56-60. PubMed ID: 19187783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of monoclonal antibodies reactive with porcine PBL.
    Pescovitz MD; Lunney JK; Sachs DH
    J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity.
    Kostenko L; Kjer-Nielsen L; Nicholson I; Hudson F; Lucas A; Foley B; Chen K; Lynch K; Nguyen J; Wu AH; Tait BD; Holdsworth R; Mallal S; Rossjohn J; Bharadwaj M; McCluskey J
    Tissue Antigens; 2011 Jul; 78(1):11-20. PubMed ID: 21501118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening a hybridoma producing a specific monoclonal antibody to HLA-A24+Bw4 antigen by cytotoxicity inhibition assay.
    Hiroishi S; Kaneko T; Arita J
    Tissue Antigens; 1987 Feb; 29(2):120-2. PubMed ID: 3299870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cytotoxic monoclonal IgM antibody (Tü 101) directed against an antigenic determinant shared between the HLA-A allospecificities A2 and A28.
    Müller C; Liangru S; Schneider M; Ziegler A; Wernet P
    Hum Immunol; 1983 Apr; 6(4):189-97. PubMed ID: 6188732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
    Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
    Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new polymorphic determinant distinct from but expressed concomitantly with an HLA-Bw44 specificity.
    Sparrow RL; McKenzie IF
    Tissue Antigens; 1984 Jan; 23(1):50-7. PubMed ID: 6199868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.
    Eiermann TH; Krause S; Wölpl A; Ballas M; Goldmann SF
    Hybridoma; 1989 Aug; 8(4):467-74. PubMed ID: 2476377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cytotoxic anti-HLA-AB monoclonal antibody which in dilution becomes specific to HLA-A3 crossreacting group.
    Mazzilli MC; Cascino I; Porrini SC; Lavaggi MV; Lulli P; Morellini M; Testa L; Gandini E
    Tissue Antigens; 1984 Aug; 24(2):107-12. PubMed ID: 6208633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.
    Pettersen RD; Hestdal K; Lee N; Geraghty DE; Valø ET; Lie SO; Gaudernack G
    Tissue Antigens; 1995 Mar; 45(3):203-12. PubMed ID: 7539160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical importance of variation within the HLA-Bw4 complex.
    Collins RW; Harmer AW; Heads AJ; Kondeatis E; Page G; Vaughan RW
    Transplantation; 2001 Dec; 72(11):1851-3. PubMed ID: 11740403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody against an epitope common to HLA-b locus antigens.
    Billing R; Lucero K
    Hum Immunol; 1982 Jul; 4(4):351-7. PubMed ID: 6181038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "public" determinants HLA-Bw4/Bw6 do not generate cytotoxic T lymphocytes (CTLs).
    López-Larrea C; Arnaiz-Villena A
    Cell Immunol; 1989 Oct; 123(2):441-4. PubMed ID: 2790969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.
    Kolstad A; Toubert A; Weyl D; Jun G; Hannestad K
    Hum Immunol; 1992 Jun; 34(2):77-84. PubMed ID: 1385373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cytotoxic monoclonal human hybridoma antibody (TrJ3) against HLA-B44(12) and -B45(12).
    Ge J; Bratlie A; Hannestad K
    Tissue Antigens; 1992 May; 39(5):258-61. PubMed ID: 1384167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.